EFEMP2 and breast cancer: EFEMP2 significantly inhibits the invasion and metastasis of tumor cells and the process of epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin pathway in lung, bladder, and breast cancers (19–21).